Work

P-CD19CD20-ALLO1: Potent Fully Allogeneic CAR-T Therapy Targeting CD19 and CD20 with Superior Efficacy over Single-Target Products

Year: 2024

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2024-211441

Authors: Samy Jambon, Jennifer Ruiz, Andres Garcia-Maldonado, Meixuan Chen, Danny Mendoza, Garrett Arauz, Nicholas DeMarco, Mona Connerney, Jeff D Eskew, Rajesh Belani, Stacey A Cranert, Julia Coronella, Devon J Shedlock

Institution: Poseida Therapeutics (United States)

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405038990

Cites:

Cited by: 2

Related to: 10